This free CME webinar was developed in response to changes made by the Substance Abuse and Mental Health Services Administration (SAMHSA) to the 42 CFR Part-2 confidentiality rule. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain recent changes to the 42 CFR Part-2 confidentiality rule.
  • Describe how changes to the rule further integrate addiction treatment into the health care system.
  • Appraise which treatment programs are subject to the final 42 CFR Part-2 rule.
  • Differentiate circumstances in which health providers can disclose patient treatment information. 
  • Define “general designation” as a collective group of medical professionals with disclosure privileges.
  • Identify health service providers that are defined as a qualified service organizations under the revised 42 CFR Part-2 rule. 
  • Explain a patient’s right to request lists of professionals given “general designation” privileges and those with access to health information. 

Target Audience

  • Addiction medicine specialists
  • Opioid treatment program providers
  • DATA-waived provider
  • Public health management services providers


There are no products which match your search criteria.

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Accreditation Statement:

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.